ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1653

Bilateral vs Unilateral Total Knee Arthroplasty: Racial Variation in Utilization and In-Hospital Major Complication Rates

Bella Mehta1, Kaylee Ho2, Jennifer Bido3, Stavros Memtsoudis3, Michael Parks4, Susan Goodman1, Linda Russell5 and Said Ibrahim6, 1Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 2Weill Cornell Medicine, New York, 3Hospital for Special Surgery, New York, 4Hospital for Special Surgery, Weill Cornell Medicine, New York, 5Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, 6Weill Cornell Medicine, Cleveland, OH

Meeting: ACR Convergence 2020

Keywords: Demographics, Disparities, Osteoarthritis, Outcome measures, Total joint replacement

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2020

Title: Osteoarthritis – Clinical Poster II

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: Compared to White Patients, African Americans (AAs) are reported to have lower utilization and higher complication rates outcomes in Unilateral Total knee arthroplasty (UTKA). It is unclear whether racial variations exist for Bilateral TKA (BTKA)

Methods: In this retrospective analysis, we sought to examine BTKA vs UTKA utilization and in-hospital complications comparing AAs and Whites. Using the National Inpatient Sample (NIS)- Healthcare Cost and Utilization Project (HCUP) database (2007-2016), we computed differences in temporal trends in utilization and major in-hospital complication rates of BTKA vs UTKA comparing AAs and Whites. All patients ≥ 50 years who underwent elective primary TKA were included. We performed multivariable logistic regression models to assess racial differences in trends adjusting for individual (age, sex, Elixhauser comorbidity index, and morbid obesity), hospital level (hospital volume, bed size, region and teaching status) and community level (median household income) variables. Discharge weights were used to enable nationwide estimates. We used multiple imputation procedures to impute values for 12% missing race information.

Results: An estimated 276,194 BTKA and 5,528,429 UTKA were performed in US. The proportion of BTKA amongst all TKAs declined from 5.53% in 2007-08 to 4.03% in 2015-16. AAs were significantly less likely to undergo BTKA compared to Whites throughout the study period (4.68% in AAs vs 6.08% in Whites in 2007-08, whereas 3.28% AAs vs 4.19% Whites in 2015-16, trend P < 0.001). In-hospital complication rates for UTKA were higher in AAs compared to Whites throughout the study period (1.35% Whites vs 1.50% AAs, 2007-08, 1.00% Whites vs 1.35% AAs in 2015-16, trend P < .0001). However, for BTKA, the in-hospital complication rates varied between Whites and AA throughout the study period (1.21% Whites vs 1.27% AAs, 2007-08; 1.03% Whites vs. 1.08% AAs, 2011-12; 0.86% Whites and 0.92% AAs, 2015-16, trend P = 0.09).

Conclusion: In this nationwide sample of patients from 2007-2016 who underwent total knee arthroplasty, the utilization rate of BKTA was higher in Whites compared to AAs. On the other hand, while AAs have consistently higher in-hospital complication rates in UTKA over the time period, this pattern was not consistent for BTKA.

Weighted frequencies and percentages of demographic characteristics among unilateral TKA vs. bilateral TKA.

Utilization of Bilateral Total Knee Arthroplasty (TKA) amongst all TKAs stratified between Whites and African Americans.

Unilateral and Bilateral Total knee Arthroplasty in-hospital Complications in Whites and African Americans


Disclosure: B. Mehta, Novartis, 1; K. Ho, None; J. Bido, None; S. Memtsoudis, Teikoku, 1, Sandoz Inco, 1, HATH, 1; M. Parks, ZimmerBiomet, 1; S. Goodman, Pfizer, 1, Novartis, 1, UCB, 1, regenosine, 1, 2, Horizon, 1; L. Russell, None; S. Ibrahim, None.

To cite this abstract in AMA style:

Mehta B, Ho K, Bido J, Memtsoudis S, Parks M, Goodman S, Russell L, Ibrahim S. Bilateral vs Unilateral Total Knee Arthroplasty: Racial Variation in Utilization and In-Hospital Major Complication Rates [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/bilateral-vs-unilateral-total-knee-arthroplasty-racial-variation-in-utilization-and-in-hospital-major-complication-rates/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/bilateral-vs-unilateral-total-knee-arthroplasty-racial-variation-in-utilization-and-in-hospital-major-complication-rates/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology